Albertsons Companies (NYSE: ACI), the supermarket operator behind Safeway, Jewel-Osco, and Vons, is drawing renewed attention after its fiscal fourth quarter results revealed the weakest revenue growth among its grocery peers. The stock has retreated sharply from post-earnings levels and is now trading near the lower end of its 52-week range, raising questions about near-term support and longer-term value.
At a Glance
- ACI last traded at $14.11, up 1.47% on the day as of June 21, 2026
- 52-week range: $13.31 to $18.22, with the stock hovering just above the floor
- Market capitalization: $6.81 billion
- Dividend yield: 4.82%, one of the more generous payouts in the grocery sector
- Q4 revenues came in at $19.12 billion, up 1.9% year over year
| Price | 14.11 USD |
|---|---|
| Day change | +0.21 (+1.47%) |
| 52-week range | 13.31 – 18.22 |
| Market cap | $6.81B |
| Dividend yield | 4.82% |
| RSI (14) | 35.91 |
| Volume | 2,663,299 |
What Albertsons Does and Why It Matters Now
Albertsons operates more than 20 grocery banners across 34 states, making it one of the largest food and drug retailers in the United States. Its store network sells conventional groceries, pharmacy services, and a range of proprietary brand products. The business is capital-intensive and margin-constrained by nature: fresh produce, refrigerated meat, and pharmacy inventory carry spoilage risk and procurement complexity that most other retail categories do not.
That backdrop matters when sizing up the Q4 print. Revenue of $19.12 billion matched analyst consensus, representing growth of 1.9% year over year. Chief Executive Susan Morris described the quarter as reflecting "disciplined execution and resilience," pointing to solid adjusted EBITDA despite what she called "meaningful top-line pharmacy-related headwinds." The EBITDA beat was a genuine bright spot; gross margin came in line with expectations rather than disappointing.
Even so, Albertsons posted the softest revenue growth among the four grocery names tracked this past earnings cycle and was the weakest performer against analyst estimates as a group. That relative underperformance has weighed heavily on the stock. ACI fell roughly 17.4% after reporting, and even with the modest rebound to the current $14.11, shares remain far from the $18.22 high recorded over the past year.
The Grocery Sector in Context
The Q4 earnings round for grocery stocks told a mixed story. As a group, the four names tracked beat consensus revenue estimates by a collective 0.7%, and shares are up an average of 3.1% since those reports landed. Albertsons is a clear outlier on the downside within that grouping.
By comparison, Sprouts Farmers Market (NASDAQ: SFM) put up 4.1% year-over-year revenue growth of $2.33 billion and has rallied 18.7% since reporting, now trading near $84.40. Grocery Outlet (NASDAQ: GO) grew revenues 3.6% to $1.17 billion, beating estimates by 1.4%, and the stock has surged 22.3% to $9.47. Even Kroger (NYSE: KR), which posted $46.12 billion in revenue, a 2.2% gain that also beat by 1.4%, has only slipped 11% despite a gross margin miss. Each of those companies outgrew Albertsons on the top line last quarter.
Grocery is structurally non-discretionary: consumers buy food regardless of economic cycles. That defensive quality partly explains why these stocks held up reasonably well through a period when markets shifted from worrying about artificial intelligence compressing software margins to fretting over geopolitical risk tied to U.S. tensions with Iran. In periods of macro anxiety, essentials-focused retailers can attract capital seeking shelter from volatility, though their upside is limited by thin margins and intense competition from warehouse clubs and online players.
What the Numbers Say
Valuation
At a market cap of $6.81 billion against trailing revenues running well above $80 billion annually, ACI trades at a slim price-to-sales multiple consistent with low-margin food retail. The source data available for this period does not include a reported price-to-earnings ratio or trailing EPS figure that can be independently confirmed, so extrapolating precise forward multiples would be speculative. What can be said with confidence is that at $14.11, the stock is pricing in a considerable amount of risk. Its 52-week low of $13.31 is less than 6% below the current price, meaning the market is already reflecting a pessimistic scenario.
Momentum
The RSI reading of 35.91 puts ACI squarely in oversold territory, below the conventional 40 threshold that many technicians watch and approaching the 30 level that signals more severe selling exhaustion. That kind of reading can attract contrarian interest, though oversold conditions can persist for extended periods when the underlying fundamental story is unclear. The stock's positioning near the bottom of its 52-week range reinforces the picture of a name under sustained distribution rather than temporary volatility.
Yield
A dividend yield of 4.82% at the current price is compelling in the context of grocery sector peers and compares favorably to broader market averages. The caveat, as always with high-yield situations, is that the yield is partly elevated because the stock price has fallen. Whether the payout is sustainable depends on free cash flow generation and the pace of any further deterioration in pharmacy revenues, the headwind Morris explicitly called out in the earnings commentary.
Bull Case vs. Bear Case
The Case for ACI
The adjusted EBITDA beat in Q4 suggests the company is managing its cost structure even as the top line grows slowly. Revenue matched expectations, avoiding the kind of guidance collapse that could trigger deeper institutional selling. A yield approaching 5% provides a meaningful total-return cushion as long as the dividend holds. The RSI near 36 signals a stock that has already absorbed substantial selling pressure, and any positive news on pharmacy headwinds, which appear to be a transitional rather than permanent drag, could provide a meaningful catalyst for recovery toward the midpoint of the 52-week range.
The Risks
The bear case is not hard to construct. Albertsons recorded the slowest revenue growth of its peer group for the quarter, and the 17.4% post-earnings decline suggests institutional investors are not giving management the benefit of the doubt. Pharmacy headwinds are real and could persist, squeezing a revenue line that carries better margins than center-store grocery. Competition from Kroger at scale and from discount operators like Grocery Outlet on price remains relentless. E-commerce penetration in food retail is still growing, and while grocery lags other categories in online adoption, the direction of travel is clear. The stock's proximity to its 52-week low, with only a narrow gap above $13.31, means there is limited technical support if sentiment deteriorates further.
Frequently Asked Questions
Why has Albertsons stock dropped so much recently?
ACI fell approximately 17.4% following its fiscal Q4 earnings report. While revenues met expectations and adjusted EBITDA beat estimates, the company posted the weakest revenue growth among its grocery peers and cited meaningful pharmacy-related headwinds, which disappointed investors looking for a clearer recovery narrative.
What grocery banners does Albertsons operate?
Albertsons operates more than 20 banners across 34 states. Well-known names in its portfolio include Safeway, Jewel-Osco, and Vons, alongside pharmacy services integrated into many of its store locations.
Is the Albertsons dividend safe?
The current yield of 4.82% reflects both the dividend rate and the depressed share price. The company generated solid adjusted EBITDA in Q4, which supports cash flow for the payout in the near term, but pharmacy headwinds and thin grocery margins are factors worth monitoring closely over coming quarters.
How does Albertsons compare to Kroger and Sprouts?
In the most recent quarter, Albertsons grew revenues 1.9% year over year compared with 2.2% for Kroger and 4.1% for Sprouts. Both Kroger and Sprouts beat analyst revenue estimates while Albertsons came in roughly in line, making it the relative underperformer of the group on growth metrics.
Where ACI Stands Heading Into the Second Half
Albertsons enters the second half of 2026 with a discounted valuation, an oversold technical profile, and a dividend yield that has become one of the more visible arguments in its favor. The pharmacy headwinds acknowledged by management are the key variable: if that pressure eases, the EBITDA story improves meaningfully. If it persists or worsens, the combination of slow revenue growth and competitive pressure from better-performing peers makes the path back toward the $18 range a long one. The gap between $14.11 and the 52-week low of $13.31 is narrow enough that investors tracking this name will be watching the next earnings cycle closely for any sign of inflection.
